Bevacizumab combined with docetaxel, oxaliplatin, and...

Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study

Meulendijks, Didier, de Groot, Jan Willem B., Los, Maartje, Boers, James E., Beerepoot, Laurens V., Polee, Marco B., Beeker, Aart, Portielje, Johanna E.A., Goey, Swan H., de Jong, Robert S., Vanhoutvi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
122
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.29864
Date:
May, 2016
File:
PDF, 344 KB
english, 2016
Conversion to is in progress
Conversion to is failed